Table 3. Overall survival for stage IV disease of all histologic subtypes.
| Overall survival | TC | GCC | NEC | MANEC | Adenocarcinoma |
|---|---|---|---|---|---|
| 1-year OS | 86.7% | 85.7% | 54.8% | 75.0% | 79.0% |
| 2-year OS | 86.7% | 45.0% | 54.8% | 41.3% | 60.9% |
| 3-year OS | 86.7% | 32.9% | 27.4% | 26.3% | 51.6% |
| 4-year OS | 86.7% | 32.9% | 27.4% | 26.3% | 40.8% |
TC, typical carcinoids; GCC, goblet cell carcinoids; NEC, neuroendocrine carcinomas; MANEC, mixed adenoneuroendocrine carcinomas.